Navigation Links
Winner Medical Group inc. Prices Offering of 1,380,000 Shares of Common Stock
Date:4/26/2010

SHENZHEN, China, April 26 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton(R) materials for the medical and consumer products industries, announced today that it has priced a public offering of 1,380,000 shares of its common stock at a price of $6.10 per share. Winner Medical expects to receive net proceeds of approximately $8.0 million from the sale of the common stock. Winner Medical has granted a 30-day option to the underwriters to purchase up to an additional 207,000 shares to cover over-allotments, if any. The offering is subject to customary closing conditions and is expected to close on or about Friday, April 30, 2010.

Winner Medical intends to use the net proceeds from this offering to expand the production capacity of its PurCotton(R) product line and for general corporate and working capital purposes.

Roth Capital Partners, LLC is acting as the sole book-running manager for the public offering, with Maxim Group LLC acting as co-manager.

The offering is being made pursuant to a shelf registration statement filed with the Securities and Exchange Commission (SEC) on March 3, 2010, which became effective on March 18, 2010. The offering will be made by a prospectus supplement, which has been filed with the SEC.

Copies of the prospectus supplement may be obtained from the offices of Roth Capital Partners,
'/>"/>

SOURCE Winner Medical Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology news :

1. Dr. Alecia Willis honored as the 2010 Signature Genomic Laboratories Travel Award winner
2. Joshua E. Neimark Memorial Travel Assistance Award winners
3. Biophysical Society announces winners of 2010 Student Travel Awards
4. Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners
5. Leibniz Prize 2010: 10 winners receive honor, prize money and idyllic freedom
6. 2009 winner of the Manpei Suzuki international prize for diabetes research announced
7. Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix
8. Winners of the 2009 AAAS Kavli science journalism awards
9. CSIRO medal winners
10. Entomological Society of America names 2009 award winners
11. Academies announce winners of 2009 Communication Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... University researchers have developed a new method for ... holes in the cell surface. The technique could ... related biological fields. , Bulk electroporation a ... reversible nanopores in the cell membrane that are ... is an increasingly popular method of cell transfection. ...
(Date:5/21/2013)... new University of Michigan Water Center today awarded ... Great Lakes restoration and protection efforts. , The ... diverse projects, including efforts to track the remediation ... techniques to control non-native weedy plant invasions; study ... fish responses to restoration activities. , The grants ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
Breaking Biology News(10 mins):Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Do men's and women's hearts burn fuel differently? 2
... A&M Institute of Renewable Natural Resources have discovered fresh remains ... Texas, according to a research associate with the institute. ... individual of false spike "Quadrula mitchelli" with tissue still in ... alive in the San Saba River in ...
... at the Gladstone Institutes have gained new insight into the ... can prevent the normal development of stem cells in the ... cancer. "The news, being announced in a paper published ... the understanding of the role of stem cells in embryonic ...
... new research that could have implications for improving fertilization ... between individual sperm and eggs in red abalone, an ... models of these interactions. They are the first scientists ... natural habitat of the abalone in the laboratory, the ...
Cached Biology News:Researchers discover freshwater mussel species thought to be extinct 2Researchers discover freshwater mussel species thought to be extinct 3Researchers discover freshwater mussel species thought to be extinct 4Gladstone scientists offer new insight into the regulation of stem cells and cancer cells 2Gladstone scientists offer new insight into the regulation of stem cells and cancer cells 3UCLA life scientists' study of abalone yields new insights into sexual reproduction 2UCLA life scientists' study of abalone yields new insights into sexual reproduction 3UCLA life scientists' study of abalone yields new insights into sexual reproduction 4
(Date:5/22/2013)... , May 22, 2013  Cleveland BioLabs, Inc. (NASDAQ: CBLI) ... the Second Annual Marcum LLP Microcap Conference, May 30, in ... Neil Lyons , CPA, Chief Financial Officer ... programs on May 30 at 1:30 p.m. Eastern Time.  A ... available on the Investors page of the Cleveland BioLabs website ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 A ... effects of probiotics on athletes to find that those who ... percent longer. The results from the study showed that in ... Probiotic Action, known for their adult acne treatment ... acne, and how it may help their skin condition. ...
(Date:5/21/2013)... , May 22, 2013 First ... formulation of glycopyrronium bromide designed using Prosonix, particle engineering ... developing a portfolio of inhaled Respiratory Medicines by ... with PSX1002 that will assess its effect on lung ... in patients with moderate to severe chronic obstructive pulmonary ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
... in Second Pivotal Clinical Trial , WASHINGTON, Nov. ... today announced positive results from BLISS-76, the second of ... for treating systemic lupus. A full presentation of ... Annual Scientific meeting of the American College of Rheumatology. ...
... powder from her ring into wine glasses carelessly left unattended. ... holding a cabochon or faceted gemstone that can be broken ... so large it is rather odd nobody seems to notice ... the "smart capsule" devised in Younan Xia,s laboratory at ...
... DIEGO and INDIANAPOLIS, Oct. 30, 2009 Amylin Pharmaceuticals, Inc., ... LLY ) today announced that the U.S. Food and ... (exenatide) injection. BYETTA is now approved for use as a ... glycemic control in adults with type 2 diabetes. Previously, it ...
Cached Biology Technology:Promise of a New Lupus Treatment Is a Groundbreaking Achievement 2Promise of a New Lupus Treatment Is a Groundbreaking Achievement 3An exquisite container 2An exquisite container 3An exquisite container 4An exquisite container 5BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 2BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 3BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 4BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 5BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 6BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes 7
Request Info...
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis....
Anti-Cullin-1 Host: rabbit polyclonal Species Reactivity: human, mouse Applications: IHC(P), WB, IP Storage: 4C...
Request Info...
Biology Products: